Cymbiotika Secures $25M Seed Round From Notable Investors After Achieving $150M In Revenue
Cymbiotika Raises $25M Seed After Bootstrapping to $150M in Revenue. The San Diego–based wellness brand known for its bioavailable supplements has secured a $25M Seed round after scaling to $150M in annual revenue without prior outside funding. Backed by a powerhouse roster across music, culture, business, and sports, Cymbiotika is redefining the modern wellness movement through functional nutrition and performance-driven lifestyle products.
Share: